Abstract
ABSTRACTIntegrating polygenic risk scores (PRS) into healthcare has the potential to stratify an individual’s risk of glaucoma across a broad population. Glaucoma is the most common cause of irreversible blindness worldwide, therefore effective screening for glaucoma endorsed by the population is highly important. This study assessed the attitude of unaffected individuals towards PRS testing for glaucoma, and sought to identify factors associated with interest in testing. We surveyed 418 unaffected individuals including those with a first-degree relative with glaucoma (n=193), those who had a recent eye examination (n=117), and general members of the community (n=108). Overall, 71.3% indicated an interest in taking a polygenic risk test for glaucoma. Interest was more likely in those who believed glaucoma to be a severe medical condition (OR 14.58, 95%CI (1.15-185.50), p=0.039), those concerned about developing glaucoma (OR 4.37, 95%CI (2.32-8.25), p<0.001), those with an intention to take appropriate measures regarding eye health (OR 2.39, 95%CI (1.16-4.95), p=0.019), and those preferring to know if considered to be at-risk or not (OR 4.52, 95%CI (2.32-8.83), p<0.001). These findings represent a valuable assessment of general public interest in glaucoma polygenic risk testing, which will be integral to the implementation and uptake of novel PRS based tests into clinical practice.
Publisher
Cold Spring Harbor Laboratory
Reference37 articles.
1. Primary open-angle glaucoma
2. Genetic Risk of Primary Open-angle Glaucoma
3. The number of people with glaucoma worldwide in 2010 and 2020
4. Prevalence of Open-angle Glaucoma in Australia
5. National Health and Medical Research Council. NHMRC Guidelines for the Screening, Prognosis, Diagnosis, Management and Prevention of Glaucoma. 2010:1–181. https://www.nhmrc.gov.au/about-us/publications/guidelines-screening-prognosis-diagnosis-management-and-prevention-glaucoma.